首页>Statistical methods in medical research>Analysis of phase II methodologies for single-arm clinical trials with multiple endpoints in rare cancers: An example in Ewing’s sarcoma
Analysis of phase II methodologies for single-arm clinical trials with multiple endpoints in rare cancers: An example in Ewing’s sarcoma
作者单位：Centre for Statistics in Medicine (CSM), University of Oxford, Botnar Research Centre, Oxford, UK[1]Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences (NDORMS), University of Oxford, Nuffield Orthopaedic Centre, Oxford, UK[2]Cancer Research Clinical Trials Unit (Cancer Sciences), School of Cancer Sciences, College of Medical and Dental Sciences, University of Birmingham, Birmingham, UK[3]
换一批
